Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Pandey, Neeraj ^a   Sachan, Annapurna ^a   Chen, Qi ^b   Ruebling Jass, Kristin ^b   Bhalla, Ritu ^a   Panguluri, Kiran Kumar ^a   Rouviere, Pierre E ^b   Cheng, Qiong ^b  

^a DUPONT COMPANY   (United States)

^b Experimental Station E328 B48B   (United States)

Author keywords

Buoyant density; Cell sorting; Density gradient; Downstream processing; GltA; GlyQS; Inclusion body; Percoll; Recombinant protein production

Indexed keywords

CSPA PROTEIN; CSPC PROTEIN; CSPE PROTEIN; ESCHERICHIA COLI PROTEIN; GLTA PROTEIN; TRANSFER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL INCLUSION; CELL SELECTION; DENSITY GRADIENT; ESCHERICHIA COLI; FERMENTATION; GENE DELETION; GENE IDENTIFICATION; GENE INACTIVATION; GENE LOCUS; GENETIC SCREENING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

CENTRIFUGATION, DENSITY GRADIENT; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE KNOCKOUT TECHNIQUES; GENE LIBRARY; GENETIC LOCI; INCLUSION BODIES; POVIDONE; RECOMBINANT PROTEINS; SILICON DIOXIDE;

ESCHERICHIA COLI;

EID: 84876847509     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-43     Document Type: Article

References (33)

1. Johnson IS. Human insulin from recombinant DNA technology. Science 1983, 219:632-637. 10.1126/science.6337396, 6337396.
2. Brassard DL, Grace MJ, Bordens RW. Interferon-alpha as an immunotherapeutic protein. J Leukoc Biol 2002, 71:565-581.
3. Stubgen JP. Recombinant interferon-beta therapy and neuromuscular disorders. J Neuroimmunol 2009, 212:132-141. 10.1016/j.jneuroim.2009.04.015, 19443048.
4. Ng T, Marx G, Littlewood T, Macdougall I. Recombinant erythropoietin in clinical practice. Postgrad Med J 2003, 79:367-376. 10.1136/pmj.79.933.367, 1742767, 12897214.
5. Maurer KH. Detergent proteases. Curr Opin Biotechnol 2004, 15:330-334. 10.1016/j.copbio.2004.06.005, 15296930.
6. Marston FA. The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem J 1986, 240:1-12. 1147368, 3548705.
7. Kuliopulos A. Production, Purification, and Cleavage of Tandem Repeats of Recombinant Peptides. J Am Chem Soc 1994, 116:4599-4607.
8. Zhou B, Xing L, Wu W, Zhang XE, Lin Z. Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb Cell Fact 2012, 11:10. 10.1186/1475-2859-11-10, 3398302, 22251949.
9. Villar-Pique A, Espargaro A, Sabate R, de Groot NS, Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact 2012, 11:55. 10.1186/1475-2859-11-55, 3495732, 22553999.
10. Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, Garcia-Fruitos E. Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact 2010, 9:71. 10.1186/1475-2859-9-71, 2949796, 20849629.
11. Cavallaro AS, Mahony D, Commins M, Mahony TJ, Mitter N. Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates. Microb Cell Fact 2011, 10:57. 10.1186/1475-2859-10-57, 3160874, 21787435.
12. Peternel S, Jevsevar S, Bele M, Gaberc-Porekar V, Menart V. New properties of inclusion bodies with implications for biotechnology. Biotechnol Appl Biochem 2008, 49:239-246. 10.1042/BA20070140, 17708747.
13. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M, Vera A, Ferraz RM, Aris A, Ventura S, Villaverde A. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 2005, 4:27. 10.1186/1475-2859-4-27, 1224866, 16156893.
14. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility - does more mean better?. Nat Biotechnol 2007, 25:718-720. 10.1038/nbt0707-718, 17621288.
15. Chotani G, Dodge T, Hsu A, Kumar M, LaDuca R, Trimbur D, Weyler W, Sanford K. The commercial production of chemicals using pathway engineering. Biochim Biophys Acta 2000, 1543:434-455. 10.1016/S0167-4838(00)00234-X, 11150618.
16. Keasling JD. Manufacturing molecules through metabolic engineering. Science 2010, 330:1355-1358. 10.1126/science.1193990, 21127247.
17. Choi JH, Keum KC, Lee SY. Production of recombinant proteins by high cell density culture of Escherichia coli. Chem Eng Sci 2006, 61:876-885.
18. Cheng YS. Increased cell buoyant densities of protein overproducing Escherichia coli cells. Biochem Biophys Res Commun 1983, 111:104-111. 10.1016/S0006-291X(83)80123-5, 6403012.
19. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006, 2:2006. 0008, 1681510, 16788596.
20. Cheng Q, Ruebling-Jass K, Zhang J, Chen Q, Croker KM. Use FACS sorting in metabolic engineering of Escherichia coli for increased peptide production. Methods Mol Biol 2012, 834:177-196. 10.1007/978-1-61779-483-4_12, 22144360.
21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
22. Keng T, Webster TA, Sauer RT, Schimmel P. Gene for Escherichia coli glycyl-tRNA synthetase has tandem subunit coding regions in the same reading frame. J Biol Chem 1982, 257:12503-12508.
23. Sofia HJ, Burland V, Daniels DL, Plunkett G, Blattner FR. Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes. Nucleic Acids Res 1994, 22:2576-2586. 10.1093/nar/22.13.2576, 308212, 8041620.
24. Toth MJ, Schimmel P. Internal structural features of E. coli glycyl-tRNA synthetase examined by subunit polypeptide chain fusions. J Biol Chem 1986, 261:6643-6646.
25. Toth MJ, Schimmel P. A mutation in the small (alpha) subunit of glycyl-tRNA synthetase affects amino acid activation and subunit association parameters. J Biol Chem 1990, 265:1005-1009.
26. Neidhardt FC, Umbergar HE. Chemical composition of Escherichia coli. Escherichia coli and Salmonella : cellular and molecular biology.Volume 1 1996, 13-16. Washington DC: ASM Press, Neihardt FC, 2.
27. Goldstein J, Pollitt NS, Inouye M. Major cold shock protein of Escherichia coli. Proc Natl Acad Sci U S A 1990, 87:283-287. 10.1073/pnas.87.1.283, 53247, 2404279.
28. Jones PG, Inouye M. RbfA, a 30S ribosomal binding factor, is a cold-shock protein whose absence triggers the cold-shock response. Mol Microbiol 1996, 21:1207-1218. 10.1111/j.1365-2958.1996.tb02582.x, 8898389.
29. Phadtare S, Tyagi S, Inouye M, Severinov K. Three amino acids in Escherichia coli CspE surface-exposed aromatic patch are critical for nucleic acid melting activity leading to transcription antitermination and cold acclimation of cells. J Biol Chem 2002, 277:46706-46711. 10.1074/jbc.M208118200, 12324471.
30. Park SJ, McCabe J, Turna J, Gunsalus RP. Regulation of the citrate synthase (gltA) gene of Escherichia coli in response to anaerobiosis and carbon supply: role of the arcA gene product. J Bacteriol 1994, 176:5086-5092. 196348, 8051021.
31. Mattanovich D, Borth N. Applications of cell sorting in biotechnology. Microb Cell Fact 2006, 5:12. 10.1186/1475-2859-5-12, 1435767, 16551353.
32. Upadhyay P. Real time detection and quantification of inclusion bodies expressed in Escherichia coli by impedance measurements. Biotechnol Lett 2001, 23:839-843.
33. Siegele DA, Hu JC. Gene expression from plasmids containing the araBAD promoter at subsaturating inducer concentrations represents mixed populations. Proc Natl Acad Sci U S A 1997, 94:8168-8172. 10.1073/pnas.94.15.8168, 21575, 9223333.